TY  - JOUR 
AU  - Pineda, B.
AU  - Díaz Lagares, Ángel
AU  - Perez-Fidalgo, J. A.
AU  - Burgues, O.
AU  - Gonzalez-Barrallo, I.
AU  - Crujeiras Martínez, Ana Belén
AU  - Sandoval, J.
AU  - Esteller, M.
AU  - Lluch, A.
AU  - Eroles, P.
PY  - 2019
SN  - 1868-7075
UR  - http://hdl.handle.net/20.500.11940/15706
AB  - BACKGROUND: Pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) varies between 30 and 40% approximately. To provide further insight into the prediction of pCR, we evaluated the role of an...
LA  - eng
KW  - Adult
KW  - Neoadjuvant Therapy
KW  - Microtubule-Associated Proteins
KW  - Middle Aged
KW  - Myogenic Regulatory Factors
KW  - Gene Expression Profiling
KW  - Taxoids
KW  - Nuclear Proteins
KW  - Triple Negative Breast Neoplasms
KW  - Cell Line
KW  - Humans
KW  - Treatment Outcome
KW  - Minor Histocompatibility Antigens
KW  - High-Throughput Nucleotide Sequencing
KW  - DNA Methylation
KW  - Gene Expression Regulation
KW  - Aged
KW  - Repressor Proteins
KW  - Sequence Analysis
TI  - A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
DO  - 10.1186/s13148-019-0626-0
T2  - CLINICAL EPIGENETICS
KW  - IDIS
VL  - 11
ER  -